Focal uptake of 68Ga-DOTATOC in the pancreas: pathological or physiological correlate in patients with neuroendocrine tumours?

A 5‐decade analysis of 13,715 carcinoid tumors

Irvin M. Modlin, Kevin D. Lye, Mark Kidd · Cancer · 2003 · 2.7K citations

Medicine, Oncology, Cancer Epidemiology +10

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

Michael Gabriel, Clemens Decristoforo, Dorota Kendler et al. · Journal of Nuclear Medicine · 2007 · 1K citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands

Jean Claude Reubi, Beatrice Waser, Jean‐Claude Schaer et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2001 · 651 citations

Medicine, Endocrinology, Oncology +11

Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data

Michael Hofmann, Helmut R. Maëcke, A. Börner et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2001 · 541 citations

Medicine, Nuclear Medicine, Radiology +14

Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours

Inga Buchmann, Marcus Henze, Swantje Engelbrecht et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2007 · 507 citations

Medicine, Nuclear Medicine, Oncology +14